What are the established guidelines for the administration of Cytarabine for acute myeloid leukemia?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18196932
Cited by: 0

Abstract

Cytarabine is commonly used in the 7+3 induction regimen and high-dose consolidation therapy for AML, with established efficacy requiring careful management of associated toxicities.

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
9 January 2026